CD274 and neoplasm: Significant post-radiotherapy improvements in the tumor’s suppressive immune microenvironment, reduced fibrosis, normalized tumor vasculature, and activation of the PD-1/PD-L1 checkpoint pathway revealed by biomarker analyses, so improving the efficacy of immunotherapy.